We're thrilled to share that MoleculeX has been selected as one of the 2026 Meet Neo Star Top 30 startups in Taiwan! Selected from over 200 startups featured by Meet Startup (創業小聚) , we're truly grateful to be recognized alongside so many inspiring and innovative teams! 💙 A huge thank you to the Meet Startup team for your dedication to supporting Taiwan's startup ecosystem, and for taking the time to interview us and share our story. We're truly grateful to have you as part

What an exciting and productive week for MoleculeX in Japan! From October 7-9, our team attended BioJapan 2026 in Yokohama and Medical Japan 2026 in Chiba, two major healthcare exhibitions taking place simultaneously this year! With both exhibitions happening at the same time, our schedule was definitely packed! But we're thrilled that we managed to attend all our important meetings and connect with everyone we had hoped to meet. 💪 We were truly encouraged by the interest in

We are incredibly honored to be selected as the recipient of the Mr. Ding Qing-San Memorial Scholarship (丁清三紀念獎金) and to have the opportunity to share MoleculeX's progress at the NTHU Garage (清大創業車庫) Demo Day! In the early days of MoleculeX, NTHU Garage played an important role in supporting our growth. Returning to this familiar place, now a little further along with a few milestones to share, makes this recognition especially meaningful to us. It truly feels like coming bac

We are pleased to announce that MuCover® Oral Wound Dressing, independently developed by MoleculeX, has recently received official notification from the U.S. Food and Drug Administration (U.S. FDA) and obtained U.S. FDA 510(k) clearance as a medical device. This milestone provides MuCover® Oral Wound Dressing with an important regulatory foundation for entering the U.S. medical device market. U.S. FDA 510(k) clearance is a key requirement for medical devices seeking market

🌏 Moving Forward Toward Global Markets: MoleculeX's Recent Progress Recently, MoleculeX has continued to make progress. 🚀 On the product side, we are advancing our mucosal adhesion technology platform through two core product directions: an oral wound dressing for clinical care settings and an intra oral patch for daily-use oral care scenarios. We are also continuing to develop additional products based on this platform. 🚀 From a regulatory perspective, our oral wound dr

This interview gave us a meaningful moment to reflect on how far MoleculeX has come, from a simple idea to where we are today. In the beginning, we spent countless days in the lab, repeating experiments again and again. Many times, we failed. Many times, we were not sure whether we were moving in the right direction. We did not know if the market would understand our product, or if anyone would be willing to use it. But step by step, we kept learning from clinical needs, impr

On May 7, we visited Chi Mei Medical Center (奇美醫院) in Tainan to share the latest clinical cases and practical experience with oral wound dressing. During the visit, we demonstrated practical tips for improving adhesion in the oral mucosa, especially in situations that may be more challenging in clinical practice. We also had valuable discussions with physicians and nurse practitioners on different clinical experiences. 🤝 Every clinical exchange gives us new insights and help

Thank you to our friends from Isura for visiting us all the way from Canada. Isura is an independent Canadian organization focused on verification, certification, and analytical testing for natural health and food products. Their work reflects a strong commitment to quality, accountability, and consumer trust in the health and wellness industry. It was a great pleasure to welcome you to Taiwan and share our journey at MoleculeX. Through this visit, we had the opportunity to e

At the beginning of March, we had the opportunity to visit Medical Japan 2026. It was a short but highly meaningful trip. During our time in Japan, we connected with a wide range of innovators, industry professionals, and potential partners 🤝. Through these conversations, we exchanged ideas, explored different perspectives, and gained valuable insights into how healthcare solutions are evolving across different markets. We also had the chance to engage with local experts,

On February 11, we were honored to present at the Healthcare Conference Taipei 2026 hosted by J.P. Morgan and UC Berkeley at The Regent Taipei. Compared to our last presentation, we have achieved important milestones 🚀, expanded our clinical footprint, and made significant progress in strengthening our bioadhesive technology. 💪 Thanks to the UC Berkeley School of Public Health for the opportunity. And thank you to everyone we had the pleasure of meeting. 😊